KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Invested Capital (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Invested Capital for 13 consecutive years, with 0.29% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 3.0% to 0.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29%, a 3.0% increase, with the full-year FY2025 number at 0.14%, down 1.0% from a year prior.
  • Return on Invested Capital was 0.29% for Q4 2025 at AbbVie, down from 18.86% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 18.86% in Q3 2025 to a low of 0.23% in Q4 2023.
  • A 5-year average of 1.68% and a median of 0.43% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: plummeted -143bps in 2021, then soared 1810bps in 2025.
  • AbbVie's Return on Invested Capital stood at 0.3% in 2021, then increased by 10bps to 0.33% in 2022, then tumbled by -31bps to 0.23% in 2023, then increased by 17bps to 0.27% in 2024, then increased by 9bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Return on Invested Capital are 0.29% (Q4 2025), 18.86% (Q3 2025), and 5.4% (Q2 2025).